Blueprint Medicines gets grant for treatment of RET-altered non-small cell lung cancer

6h ago, source: Pharmaceutical Technology

Treat RET-altered lung cancer with Blueprint Medicines Corp's patented method using Compound 1. Learn about dosages and administration for optimal results.

Decoding 6 Analyst Evaluations For Blueprint Medicines

12d ago, source:

In the assessment of 12-month price targets, analysts unveil insights for Blueprint Medicines, presenting an average target ...

Piper Sandler Keeps Their Hold Rating on Blueprint Medicines (BPMC)

1d ago, source:

In a report released today, Christopher Raymond from Piper Sandler maintained a Hold rating on Blueprint Medicines (BPMC – Research ...

Blueprint Medicines Corporation (NASDAQ:BPMC): When Will It Breakeven?

25d ago, source: Yahoo Finance

Blueprint Medicines Corporation (NASDAQ:BPMC) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Blueprint Medicines Corporation ...

Blueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shines

2mon ago, source: Zacks.com on MSN

Blueprint Medicines Corporation BPMC reported a fourth-quarter 2023 loss of $1.82 per share, narrower than the Zacks ...

Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics

12d ago, source:

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced it will launch a webcast series to provide scientific ...

First Week of May 17th Options Trading For Blueprint Medicines (BPMC)

1mon ago, source: Nasdaq

Investors in Blueprint Medicines Corp (Symbol: BPMC) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Blueprint Medicines Corp BPMC

19d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Blueprint Medicines Corp (BPMC)

1mon ago, source: Investing

Blueprint Medicines Corp 's (NASDAQ:BPMC) Chief Financial Officer, Michael Landsittel, has recently engaged in transactions involving the company's stock, according ...

Blueprint Medicines Corp

25d ago, source: U.S. News & World Report

A slump in renewable energy stocks means long-term opportunities aren't baked into some valuations.